The Beacon Award

The Beacon Award

The AIM-HI Beacon Award for Women Leaders in Oncology recognizes outstanding women leaders in all sectors of the health and life sciences industry who have made a significant impact on advancing cancer treatment, detection, and diagnosis for patients worldwide through the development and commercialization of novel technologies, advocacy, and/or implementation of public policy.

2023 Beacon Award Selection Committee Members

  • Sujuan Ba, Ph.D., Co-Chair, CEO & Co-Founder, AIM-HI Accelerator Fund; President & CEO, National Foundation for Cancer Research
  • Webster Cavenee, Ph.D., Co-Chair, Distinguished Professor Emeritus, University of California San Diego
  • Anna D. Barker, Ph.D., Chief Strategy Officer, Ellison Institute for Transformative Medicine (2022 Winner)
  • Deborah Dunsire, M.D., President & CEO, Lundbeck
  • Bahija Jallal, Ph.D., CEO & Director of the Board, Immunocore
  • Karen Knudsen, MBA, Ph.D., CEO, American Cancer Society
  • Andrew Plump, M.D., Ph.D., President, Research & Development, Takeda Pharmaceutical

Previous Recipients

2023 Winner

Monica M. Bertagnolli, M.D.
Director, National Cancer Institute

2022 Winner

Anna D. Barker, Ph.D.
Chief Strategy Officer, Ellison Institute for Transformative Medicine
Distinguished Visiting Fellow, Complex Adaptive Systems, Arizona State University